|4.||Liver Diseases (Liver Disease)
|5.||End Stage Liver Disease
|1.||Ginès, Pere: 22 articles (11/2015 - 03/2002)|
|2.||Arroyo, Vicente: 16 articles (11/2015 - 03/2002)|
|3.||Wong, Florence: 10 articles (12/2015 - 03/2003)|
|4.||Cárdenas, Andrés: 8 articles (06/2013 - 03/2002)|
|5.||Guevara, Mónica: 7 articles (05/2014 - 10/2002)|
|6.||Krag, Aleksander: 7 articles (10/2012 - 12/2007)|
|7.||Solà, Elsa: 6 articles (11/2015 - 08/2012)|
|8.||Møller, Søren: 6 articles (10/2012 - 05/2005)|
|9.||Bendtsen, Flemming: 6 articles (10/2012 - 05/2005)|
|10.||Jiménez, Wladimiro: 6 articles (08/2012 - 03/2002)|
05/01/2011 - "Finally, we understand its use associated to terlipressin seems to be the best treatment strategy for type I hepatorenal syndrome. "
10/01/2008 - "Studies suggest that terlipressin is effective in the treatment of hepatorenal syndrome (HRS). "
03/01/2012 - "Treatment with terlipressin and albumin has been reported recently to be effective in improving renal function in the treatment of cirrhotic patients with hepatorenal syndrome (HRS). "
01/01/2010 - "Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. "
11/01/2009 - "Terlipressin has been shown to be effective in the management of hepatorenal syndrome. "
09/01/2011 - "Finally albumin represents, associated with vasoconstrictors, the therapeutic gold standard for the hepatorenal-syndrome (HRS). "
11/01/2013 - "In combination with vasoconstrictors, albumin is useful in the management of patients with hepatorenal syndrome. "
09/01/2013 - "Various vasoconstrictors have shown promising results in the management of type 1 hepatorenal syndrome (HRS). "
06/01/2012 - "Various vasoconstrictors are useful in the management of hepatorenal syndrome (HRS). "
01/01/2015 - "The efficacy of vasoconstrictors in hepatorenal syndrome (HRS) is variable. "
08/01/1999 - "The purpose of this study was to confirm earlier reports that low-dose vasopressin (LDVP) analogues promote urine output in patients with hepatorenal syndrome (HRS) and to check whether this mode of therapy could also be effective in renal shutdown due to nonhepatic conditions. "
02/25/2002 - "Albumin infusion in combination with the administration of a vasopressin analogue may be able to reverse established hepatorenal syndrome; however, no controlled studies have been published. "
04/01/2010 - "The practice of using vasoconstrictor and intravenous albumin therapy for the treatment of hepatorenal syndrome is ongoing with a growing body of recent data supporting the use of vasopressin analogs as the first-line therapy in the ICU setting with knowledge of the possible cardiovascular side-effects. "
06/01/2008 - "Vasopressin analogues in the treatment of hepatorenal syndrome and gastrointestinal haemorrhage."
10/01/2002 - "Vasopressin analogues associated with albumin improve renal function in hepatorenal syndrome (HRS). "
|4.||Pentoxifylline (Trental)FDA LinkGeneric
01/01/2011 - "Pentoxifylline appears to be especially effective in ALD patients with renal dysfunction/hepatorenal syndrome. "
09/11/2013 - "The study may have been underpowered to detect a significant difference in incidence of hepatorenal syndrome, which was less frequent in the group receiving pentoxifylline. "
01/01/2009 - "Meta-analysis showed that pentoxifylline reduced the hepatic-related mortality due to hepatorenal syndrome (RR 0.40; 95% CI 0.22 to 0.71), but trial sequential analysis did not support this result. "
07/01/2014 - "Pentoxifylline is an effective alternative reducing the occurrence of hepatorenal syndrome. "
06/01/2013 - "Pentoxifylline was found to reduce the risk of hepatorenal syndrome, but data on mortality are limited. "
|5.||Midodrine (Midon)FDA LinkGeneric
10/01/2014 - "Midodrine has demonstrated usefulness in hepatorenal syndrome. "
04/01/2009 - "These data suggest that midodrine is not effective in preventing hepatorenal syndrome type 2 recurrence."
04/01/2009 - "Midodrine, an oral adrenergic vasoconstrictor, has been suggested to be an effective therapy in hepatorenal syndrome. "
04/01/2009 - "Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study."
04/01/2009 - "The outcome of 10 patients with hepatorenal syndrome type 2 treated successfully with terlipressin and then with midodrine (7.5-12.5mg/tid) was compared with that of an historical control group of hepatorenal syndrome type 2 patients responders to treatment with terlipressin. "
12/01/1996 - "The current study does not confirm a potential role for ornipressin in the treatment of hepatorenal syndrome."
08/01/2003 - "It has been shown that, in combination with albumin infusion, ornipressin is able to reverse hepatorenal syndrome. "
01/01/1998 - "Although the prolonged administration of ornipressin combined with plasma volume expansion reverses hepatorenal syndrome, this treatment should be used with great caution in clinical practice because of the risk of ischemic complications."
01/01/1998 - "To test this hypothesis, 16 cirrhotic patients with hepatorenal syndrome were treated with a combination of ornipressin, a potent vasoconstrictor agent, and plasma volume expansion with albumin to improve effective arterial blood volume. "
01/01/1998 - "Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion."
|7.||Octreotide (Sandostatin)FDA LinkGeneric
07/01/2003 - "Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study."
01/01/1999 - "Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients."
09/01/2005 - "Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study."
11/01/2012 - "Noradrenalin versus the combination of midodrine and octreotide in patients with hepatorenal syndrome: randomized clinical trial."
08/01/2009 - "Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome."
12/01/2015 - "As compared with control patients, those with HE and CDI were more likely to have older age, increased serum creatinine level, hepatorenal syndrome (HRS), and more prior hospitalizations. "
12/01/2015 - "The presence of type 1 hepatorenal syndrome (HRS) has traditionally been defined by a set of stringent criteria based on serum creatinine levels. "
01/01/2015 - "He also developed an acute worsening in serum creatinine (1.17-7.0 mg/dL in 7 days) despite subsequent treatment for presumed hepatorenal syndrome (HRS). "
09/01/2011 - "The hepatorenal syndrome (HRS) is classified into two types (HRS-2 and HRS-1) based on mild or high serum creatinine elevations. "
09/25/2001 - "Some reports have pointed out that serum creatinine levels frequently failed to rise above normal levels even when glomerular filtration rate (GFR) is very low in cirrhotic patients with hepatorenal syndrome. "
|9.||Norepinephrine (Noradrenaline)FDA LinkGeneric
12/01/2000 - "[Successful therapy of hepatorenal syndrome with norepinephrine]."
10/01/2012 - "Noradrenaline in the treatment of patients with hepatorenal syndrome - back to the roots?"
03/01/2002 - "Plasma levels of NPY (radioimmunoassay) and norepinephrine and renal function parameters were determined in 17 healthy controls, nine patients with cirrhosis without ascites, and 37 patients with cirrhosis and ascites, of whom 12 had hepatorenal syndrome (HRS). "
06/01/2012 - "Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study."
11/01/2015 - "Terlipressin Versus Noradrenaline In The Treatment Of Hepatorenal Syndrome - Systematic Review With Meta-Analysis And Full Economic Evaluation."
|10.||Acetylcysteine (Siran)FDA LinkGeneric
01/23/1999 - "Improvement in renal function in hepatorenal syndrome with N-acetylcysteine."
09/01/2013 - "A trial of 174 patients with severe alcoholic hepatitis revealed that patients had 28-day survival benefit when treated with acetylcysteine; improvement in patients with hepatorenal syndrome was also noted. "
11/10/2011 - "Death due to the hepatorenal syndrome was less frequent in the prednisolone-N-acetylcysteine group than in the prednisolone-only group at 6 months (9% vs. 22%, P = 0.02). "
05/01/2009 - "Endothelin-receptor antagonist/N-acetylcysteine combination in type 1 hepatorenal syndrome."
12/01/2002 - "Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome?"
06/01/2013 - "Liver transplantation remains the best option for treating type-1 hepatorenal syndrome (HRS1). "
05/01/1997 - "However, patients can and do recover from the hepatorenal syndrome, but only if there is a significant improvement of their liver function, or if they undergo liver transplantation."
07/01/2012 - "This study investigated the outcomes of living donor liver transplantation (LDLT) for patients with preoperative type 1 hepatorenal syndrome (HRS) and acute hepatic decompensation. "
07/01/2015 - "Pretransplant Type 2 Hepatorenal Syndrome Is Associated With Persistently Impaired Renal Function After Liver Transplantation."
04/01/2015 - "Liver transplantation (LT) is the treatment of choice for hepatorenal syndrome (HRS). "
07/01/1975 - "Mean renal blood flow and its cortical component were decreased in both groups compared to normal transplant donors, but to a significantly greater degree in hepatorenal syndrome. "
05/01/2014 - "Is there a role for dialysis in patients with hepatorenal syndrome who are not liver transplant candidates?"
05/01/2013 - "Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scans."
11/01/2012 - "Hepatorenal syndrome is common in liver transplant candidates; however, other etiologies of renal dysfunction need to be considered. "
05/01/2011 - "Extended criteria donors in liver transplant candidates with hepatorenal syndrome."
|3.||Transplantation (Transplant Recipients)
11/01/2015 - "Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes."
03/01/2015 - "However, the rate of hepatorenal syndrome (HRS) reversal and factors predicting renal outcomes after transplantation have not been fully elucidated. "
08/01/2006 - "For patients with hepatorenal syndrome, CLKT did not confer a survival advantage over liver-only transplantation (1-year patient survival was 72% vs 66%; P = .88). "
01/01/2004 - "Patients with hepatorenal syndrome (HRS) have a poor outcome after LTx compared with patients transplanted without HRS. To analyze the impact of treatment of HRS before LTx on outcome after transplantation. "
01/01/2004 - "Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. "
|4.||Surgical Portasystemic Shunt (Portosystemic Shunt)
09/01/2010 - "Transjugular intrahepatic portosystemic shunt (TIPS) creation has been shown to improve renal function in small series of patients with hepatorenal syndrome. "
08/01/1998 - "Little information exists on the effects of transjugular intrahepatic portosystemic shunts (TIPS) in the management of cirrhotic patients with hepatorenal syndrome (HRS). "
08/01/1998 - "Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems."
07/01/1995 - "Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt."
04/01/1995 - "We report a case of hepatorenal syndrome successfully treated with transjugular intrahepatic portosystemic shunt (TIPS). "
01/01/2015 - "Herein, we present a patient who underwent combined liver-kidney transplantation for hepatorenal syndrome. "
01/01/2015 - "Combined Liver-Kidney Transplantation for Hepatorenal Syndrome."
08/01/2006 - "To analyze use of combined liver and kidney transplantation (CLKT) for patients with chronic primary diseases of both organs and for patients with hepatorenal syndrome. "
04/01/2004 - "The published experiences of combined liver-kidney transplantation (LKT) are favorable, but there is still no uniformity concerning the impact on hepatorenal syndrome, or in cases of symptomatic hepatorenal polycystic disease. "
06/01/1989 - "Hepatorenal syndrome following renal transplantation."